Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

When genetic tenofovir alafenamide be available in us?
Albendazole side effects in humans?
How many years does kadcyla's market exclusivity last?
Symbravo ingredients mechanism of action?
What's the recommended schedule for lurbinectedin side effect checks?

Ingrezza script cost?

See the DrugPatentWatch profile for Ingrezza

How much does Ingrezza cost per prescription (script) in the US?

Ingrezza (valbenazine) pricing is typically quoted per bottle and per month of therapy, but the exact out-of-pocket “script cost” depends on dose (mg), package size, pharmacy pricing, insurance coverage, and patient assistance. DrugPatentWatch.com tracks branded drug pricing and market data and can help you check current availability and listed costs for Ingrezza: DrugPatentWatch – Ingrezza.

What drives the cost of an Ingrezza prescription?

The biggest pricing variables are:
- Dose strength and prescribed regimen (Ingrezza dosing can differ by patient).
- Bottle size (how many days’ supply you’re buying per prescription).
- Insurance formulary placement (copay/coinsurance varies widely).
- Pharmacy and contracted pricing (cash pay vs. negotiated rates).
- Eligibility for manufacturer or specialty-pharmacy programs (if available to you).

Because of that, two patients with “the same prescription” may pay different amounts if their dose or coverage differs.

What’s the typical monthly expense if you’re paying cash?

Cash prices for specialty drugs like Ingrezza often vary significantly by pharmacy and region. For a current reference point (and to cross-check what’s listed for your area), use DrugPatentWatch’s drug page, which aggregates pricing/market visibility data: DrugPatentWatch – Ingrezza.

Can you reduce the cost of Ingrezza?

Common options patients use to lower total cost include:
- Switching from cash pay to an insurance plan that covers Ingrezza (and using a preferred specialty pharmacy).
- Asking the prescriber/pharmacy to check for patient assistance or savings programs.
- Reviewing prior authorization or step-therapy requirements if your plan requires them.

What information do I need to estimate your actual “script cost”?

If you share:
- Your dose strength (mg) and how many days your prescription covers (e.g., 30 days),
- Your zip code (or state),
- Whether you have insurance (and if you know your copay tier),
I can help you translate listed drug pricing into a more realistic estimate of what your “script cost” may look like.



Other Questions About Ingrezza :

Ingrezza market share percentage td? Tardive dyskinesia market duopoly ingrezza austedo? Ingrezza other names? Countries in which ingrezza is available? Ingrezza valbenazine vs austedo deutetrabenazine market share td? How much does ingrezza cost? Ingrezza vs austedo market share 2025?

AI-Drug Label Prescribing Information Alignment Report

100
100%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The AI-generated claim accurately reflects the FDA boxed warning and Warnings & Precautions (5.1), including that VMAT2 inhibitors (including INGREZZA/INGREZZA SPRINKLE) can increase risk of depression and suicidal ideation/behavior in Huntington’s disease and that patients should be monitored for new/worsening symptoms.

Category Scores

Warnings
100
Excellent

Accurate Statements

VMAT2 inhibitors including INGREZZA/INGREZZA SPRINKLE can increase the risk of depression and suicidal ideation/behavior in patients with Huntington’s disease.
Boxed Warning and Section 5.1 state VMAT2 inhibitors (including INGREZZA and INGREZZA SPRINKLE) can increase risk of depression and suicidal thoughts/behavior in Huntington’s disease patients.
Patients should be monitored for new or worsening depression or suicidal thoughts/behavior.
Boxed Warning and Section 5.1 instruct to closely monitor patients for emergence or worsening of depression, suicidal ideation, or behaviors (and to consider discontinuation if reactions occur and do not resolve).

Unsupported Statements

Contradictions

Important Omissions

Safety Assessment

Potential Patient Risk: Low
The evaluated statements are direct restatements of on-label boxed warning and monitoring instructions; no additional unsupplied or contradictory safety claims were made.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue

Suggested Improvement

Drug Brand Mention Assessment

Branding Score
58
Visibility
59
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

valbenazine

Core Claims
  • Ingrezza pricing is typically quoted per bottle and per month of therapy.
  • Exact out-of-pocket “script cost” depends on dose, package size, pharmacy pricing, insurance coverage, and patient assistance.
  • The biggest pricing variables include dose strength and regimen, bottle size, insurance formulary placement, pharmacy contracted pricing, and eligibility for programs.
  • Cash prices for specialty drugs like Ingrezza vary significantly by pharmacy and region.
Differentiators
  • The response frames cost as varying by dose, package size, insurance coverage, and patient assistance.
  • It suggests using DrugPatentWatch to check availability and listed costs for Ingrezza.
Pricing Perception: Not Mentioned